We show that unlike N-NCMs, I-NCMs migrated into both vascular and extravascular tumor microenvironments via the CCR2/CCL2 axis, where they released CCL6 to recruit NK cells that promote tumor lysis, independent of T and B lymphocytes. The gene discussed is CCL2; the disease is neoplasm.